StonvexLoading…
StonvexStonvexStonvexCore line items from BMRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.22B | $2.85B | $2.42B | $2.10B |
Operating Income | $409.48M | $484.21M | $185.77M | $160.97M |
Net Income | $348.90M | $426.86M | $167.65M | $141.56M |
EPS (Diluted) | $1.80 | $2.21 | $0.87 | $0.75 |
Total Assets | $7.59B | $6.99B | $6.84B | $6.38B |
Total Liabilities | $1.51B | $1.33B | $1.89B | $1.77B |
Cash & Equivalents | $1.31B | $942.84M | $755.13M | $724.53M |
Free Cash Flow OCF − CapEx | $724.96M | $487.42M | $62.57M | $54.94M |
Shares Outstanding | 192.30M | 190.76M | 188.60M | 186.25M |